Search

everythinglearnresearchcommunity

for

Search:↓

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Niacin deficiency makes rats more sensitive to cancer-causing chemicals.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Finasteride may help reduce impulsivity caused by pramipexole.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

We need safe, affordable drugs to fight coronaviruses effectively.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

New drug uses show promise but need more research.

Cocor Bebek leaf extract may promote hair growth better than minoxidil at high concentrations.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Cepharanthine could be a strong antiviral against COVID-19.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Cervi Parvum Cornu complex improved urinary symptoms in men without major side effects.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Dracorhodin perchlorate helps heal wounds in diabetic rats by reducing inflammation.

Polydopamine and quercetin together can speed up hair regrowth.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Calancardin B may help reduce inflammation in immune cells.

Upadacitinib effectively treats pyoderma gangrenosum.

Low-penetration genes might help personalize colorectal cancer prevention.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.